Helping Black older adults with Type 2 diabetes reduce sedentary time
Collaborative Solutions for Breaking up Sedentary Time in Black Older Adults With Type 2 Diabetes: The Interrupt Diabetes Study
This study is testing ways to help Black older adults with Type 2 diabetes move more and sit less to improve their health.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 55 Years and up |
| Sex | All |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Trial ID | NCT06283849 on ClinicalTrials.gov |
What this trial studies
This study aims to address the high rates of Type 2 Diabetes (T2D) and cardiovascular diseases among Black older adults by implementing strategies to break up sedentary behavior. It focuses on individuals aged 55 and older who self-identify as Black or African American and have a self-reported diagnosis of T2D. The intervention seeks to improve health outcomes by encouraging more physical activity and reducing prolonged periods of inactivity. The study will assess the effectiveness of these strategies in enhancing physical activity levels and overall health.
Who should consider this trial
Good fit: Ideal candidates for this study are Black or African American individuals aged 55 and older who have been diagnosed with Type 2 diabetes.
Not a fit: Patients with cognitive impairments or physical disabilities that prevent them from engaging in physical activity may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved health outcomes and quality of life for Black older adults with Type 2 diabetes.
How similar studies have performed: Other studies have shown success in similar approaches aimed at increasing physical activity and reducing sedentary behavior among older adults, particularly in minority populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identify as Black or African American. * Aged 55 years and older. * Speak and read English. * Self-reported diagnosis of T2D. Exclusion Criteria: * Evidence of cognitive impairment that could impact ability to consent and/or participation (Mini-Cog score \<3). * Physical impairment or disability that interferes with ability to engage in PA (e.g., severe osteoarthritis, lower extremity amputation \[other than toe(s)/partial foot\], regular use of a walker or wheelchair, etc.). * Unstable medical/psychiatric condition that in the opinion of the PI could impact study participation.
Where this trial is running
Minneapolis, Minnesota
- University of Minnesota — Minneapolis, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Mary O Whipple, PhD, RN, PHN — University of Minnesota
- Study coordinator: Mary O Whipple, PhD, RN, PHN
- Email: whipp042@umn.edu
- Phone: 612-625-4470
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.